Our last translational advisory board of the year dealing with aspects of autologous tumor vaccine production took place on Dec 11th. The objective was to bring cross-functional experts together and define critical pathways of tumor vaccine production to develop an optimal process as well as analytics for the future.
We are grateful to have incredibly good collaborators onboard who are adding insights into immunology, bioinformatics, analytical methods, pathology and surgery.
A big thank you to all participants !
